No Data
No Data
MediciNova: Extraordinary Report
Medicinova Inc: Quarterly Report
Medicinova, Inc.: Securities Report.
Medicinova Inc: Confirmation Letter
Express News | Medicinova Receives Notice of Allowance for New Patent Covering Mn-166 (Ibudilast) for the Prevention of Metastasis of Various Solid Cancer
Express News | MediciNova Has Received A Notice Of Allowance From The US Patent And Trademark Office For A Pending Patent Application Covering MN-166 (Ibudilast) For The Prevention Of Metastasis In Various Cancers
No Data